Target intelligence / Profile preview

X-ray repair cross-complementing protein 5 (XRCC5)

Target
XRCC5
Molecular classification
DNA-binding protein, DNA repair protein, Component of DNA-PK complex, Enzyme (ATP-dependent DNA helicase activity reported), Other (autoantigen)
01

Overview

X-ray repair cross-complementing protein 5 (XRCC5), commonly called Ku80, is a core component of the non-homologous end joining (NHEJ) DNA double-strand break repair machinery. It forms a heterodimer with Ku70 (XRCC6) to create the Ku complex, which binds to DNA double-strand break ends, initiates recruitment of other repair factors, and is crucial for maintaining genome stability. XRCC5's functions include DNA end binding, assembly of the DNA-dependent protein kinase (DNA-PK) complex, and end-processing activities required for effective repair and V(D)J recombination in immune cells. XRCC5/Ku80 also plays roles in transcriptional regulation, ribosomal RNA processing, and innate immune response. Deregulation or mutation in XRCC5 is associated with increased cancer risk, immunodeficiency, radiosensitivity, and autoimmune phenomena[1][2][3][4][5][6][7].

Other names
Ku80Ku86KARP-1KARP1KUB2CTC85CTCBFTLAAG22P2NFIVThyroid-lupus autoantigenLupus Ku autoantigen protein p86Nuclear factor IVDNA repair protein XRCC586 kDa subunit of Ku antigenATP-dependent DNA helicase 2 subunit 2ATP-dependent DNA helicase II 80 kDa subunitCTC box-binding factor 85 kDa subunitKu autoantigen, 80kDa
02

Mechanism of action

Drug candidates working at this target generally act by inhibiting DNA-dependent protein kinase (DNA-PK) activity, leading to impaired NHEJ DNA repair and sensitization to DNA-damaging agents (e.g., ionizing radiation, chemotherapy)

03

Biological functions

DNA double-strand break repairNon-homologous end joining (NHEJ) pathwayDNA end recognition and processingV(D)J recombinationRegulation of chromosomal stabilityNegative regulator of transcription in certain complexesInvolvement in immune response signaling (via cGAS-STING pathway)
04

Disease associations

Cancer (dysregulation or mutation increases tumor risk and genomic instability)Immunodeficiency (defective V(D)J recombination)Increased risk of radiation sensitivity and associated syndromesOther (autoimmune disorders due to antigenicity: e.g., lupus)
05

Safety considerations

Potential for off-target toxicity due to impairment of essential DNA repair mechanisms, leading to increased risk of secondary cancers and genomic instabilityEffects on the immune system and stem cell viability
06

Interacting drugs

No approved small-molecule drugs are directly targeting XRCC5/Ku80, but inhibitors of DNA-PK (which includes the Ku70/Ku80 complex) are under investigation as radiosensitizers in oncology
07

Biomarkers

XRCC5/Ku80 protein or genetic alterations used as biomarkers for DNA repair capacity, radiation sensitivity, and certain cancer prognostics

Beyond the preview

Go deeper on X-ray repair cross-complementing protein 5 (XRCC5).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on X-ray repair cross-complementing protein 5 (XRCC5).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call